94%
cancer patients respond well to COVID-19 vaccines: Study
Livemint
According to a new study, nearly all patients with cancer
developed a good immune response to the COVID-19 mRNA ... as co-lead author of
the study with Alfredo Addeo, MD, senior oncologist at the Geneva
University Hospital.
No comments:
Post a Comment